Suppr超能文献

雄激素受体阳性唾液腺癌的明确治疗方法是雄激素剥夺治疗和外照射放疗。

Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy.

机构信息

Department of Radiation Oncology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.

出版信息

Head Neck. 2014 Jan;36(1):E4-7. doi: 10.1002/hed.23383. Epub 2013 Sep 17.

Abstract

BACKGROUND

Salivary duct carcinoma (SDC) is an aggressive malignancy with high recurrence rates. Standard management includes surgical resection followed by adjuvant radiation. Androgen receptor positivity has been described to be present in 40% to 90% of SDCs, and a recent case series showed a benefit to androgen deprivation therapy (ADT) in recurrent or metastatic disease.

METHODS AND RESULTS

We present the case of an 87-year-old woman with a locally advanced androgen receptor-positive parotid SDC treated definitively with ADT and external beam radiotherapy, a regimen modeled after the treatment of prostate cancer. She had a complete response on positron emission tomography (PET)/CT scan and had no evidence of disease 24 months after the completion of treatment.

CONCLUSION

To our knowledge, this case report is the first to describe the use of ADT plus radiation to definitively treat SDC. This regimen could be considered in patients with androgen receptor-positive SDCs who are considered unresectable or who refuse surgery.

摘要

背景

唾液腺癌(SDC)是一种侵袭性恶性肿瘤,复发率很高。标准治疗包括手术切除加辅助放疗。雄激素受体阳性在 SDC 中约占 40%至 90%,最近的一项病例系列研究显示,在复发性或转移性疾病中,雄激素剥夺治疗(ADT)有获益。

方法和结果

我们报告了一例局部晚期雄激素受体阳性腮腺 SDC 的 87 岁女性患者,采用 ADT 和外照射放疗进行根治性治疗,该方案是根据前列腺癌的治疗方法设计的。她在正电子发射断层扫描(PET)/CT 扫描上完全缓解,治疗完成后 24 个月无疾病证据。

结论

据我们所知,本病例报告是首例描述使用 ADT 加放疗根治性治疗 SDC 的病例。对于被认为不可切除或拒绝手术的雄激素受体阳性 SDC 患者,可以考虑这种治疗方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验